[Answered] Most of the lymph returns to the venous circulation by way of the A) right lymphatic duct. B) ...

This topic contains a solution. Click here to go to the answer

Author Question: Most of the lymph returns to the venous circulation by way of the A) right lymphatic duct. B) ... (Read 69 times)

ENagel

Hero Member
Posts: 540

on: Feb 27, 2019

Most of the lymph returns to the venous circulation by way of the
A) right lymphatic duct.
B) thoracic duct.
C) cisterna chyli.
D) hepatic portal vein.
E) dural sinus.

Question 2

An infant born ________ prematurely has a good chance of survival.
A) 1.5 months
B) 3 months
C) 4 months
D) 5 months
E) 6 months

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

emsimon14

Sr. Member
Posts: 344

Reply #1 on: Feb 27, 2019

Answer to Question 1

B

Answer to Question 2

A

ENagel

Member
Posts: 540

Reply 2 on: Feb 27, 2019

Excellent

Viet Thy

Member
Posts: 329

Reply 3 on: Yesterday

Gracias!

« previous next »

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

Allergies play a major part in the health of children. The most prevalent childhood allergies are milk, egg, soy, wheat, peanuts, tree nuts, and seafood.

Did you know?

Though newer “smart” infusion pumps are increasingly becoming more sophisticated, they cannot prevent all programming and administration errors. Health care professionals that use smart infusion pumps must still practice the rights of medication administration and have other professionals double-check all high-risk infusions.

Did you know?

Asthma-like symptoms were first recorded about 3,500 years ago in Egypt. The first manuscript specifically written about asthma was in the year 1190, describing a condition characterized by sudden breathlessness. The treatments listed in this manuscript include chicken soup, herbs, and sexual abstinence.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.